Plasma cyclic guanosine monophosphate reflecting the severity of persistent pulmonary hypertension of the newborn

Biology of the Neonate

Volumn 80, Issue 2, 2001, Pages 107-112

  Turanlahti, Maila ^a,d   Pesonen, E ^b   Pohjavuori, M ^a   Lassus, P ^a   Fyhrquist, F ^c   Andersson, S ^a,c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d NONE   (France)

Author keywords

Cyclic guanosine monophosphate; Newborn; Nitric oxide; Pulmonary hypertension

Indexed keywords

ARTIFICIAL LUNG SURFACTANT; CYCLIC GMP; DOBUTAMINE; DOPAMINE; LUNG SURFACTANT EXTRACT; NITRIC OXIDE; PROSTACYCLIN;

APGAR SCORE; ARTERIAL PRESSURE; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE SEVERITY; DOPPLER FLOWMETRY; DRUG EFFECT; HUMAN; HYPOXIA; INHALATION; LUNG ARTERY PRESSURE; LUNG PRESSURE; NEWBORN; NEWBORN DISEASE; OXYGENATION; PERINATAL ASPHYXIA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; TIME;

APGAR SCORE; ASPHYXIA NEONATORUM; BLOOD PRESSURE; CYCLIC GMP; FEMALE; HUMANS; INFANT, NEWBORN; KINETICS; MALE; NITRIC OXIDE; OXYGEN; PERSISTENT FETAL CIRCULATION SYNDROME; PROSPECTIVE STUDIES; PULMONARY ARTERY;

EID: 0034880202     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000047128     Document Type: Article

References (17)

1. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn
2. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide
3. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein
4. Doppler echocardiographic measurement of pulmonary artery pressure from ductal Doppler velocities in the newborn
5. Right heart pressure determination by Doppler in infants with tricuspid regurgitation
6. Effect of inhaled nitric oxide in endothelin-1 and cyclic guanosine 5′-monophosphate plasma concentrations in newborn infants with persistent pulmonary hypertension
7. Randomized multi-central trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn
8. Decreased gene expression of endothelial nitric oxide synthase in newborn infants with persistent pulmonary hypertension
9. Major vasodilator role for nitric oxide in the gastrointestinal circulation of the mid-gestation fetal lamb
10. Ontogeny of NO activity and response to inhaled NO in the developing ovine pulmonary circulation
11. Changes in oxygenation and pulmonary haemodynamics in pre-term infants treated with inhaled nitric oxide
12. Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: A randomised controlled trial
13. Surfactant dysfunction after inhalation of nitric oxide
14. Inhaled nitric oxide injures the pulmonary surfactant system in lambs in vivo
15. The effect of nitric oxide therapy on bleeding time and platelet aggregation in neonates
16. Echocardiographic assessment of inhaled nitric oxide in newborn babies with severe hypoxaemia
17. Doppler echocardiographic assessment of pulmonary blood flow in healthy newborn infants